Regular Human Insulin
Sponsors
Pfizer, Mannkind Corporation, Biodel, Generex Biotechnology Corp., Halozyme Therapeutics
Conditions
Coronary Artery DiseaseDiabetes MellitusDiabetes Mellitus, Type 1HealthyHyperglycemiaType 1 Diabetes MellitusType 2 DiabetesType 2 Diabetes Mellitus
Phase 1
Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin
CompletedNCT00511979
Start: 1999-08-31End: 2000-06-30Updated: 2012-06-26
Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone
CompletedNCT00862849
Start: 2009-03-31End: 2009-08-31Updated: 2014-07-22
Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
CompletedNCT00982254
Start: 2001-10-31Updated: 2009-09-23
Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler
CompletedNCT01490762
Start: 2011-12-31End: 2012-07-31Updated: 2012-09-07
Phase 2
Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus
CompletedNCT00883558
Start: 2009-05-31End: 2010-04-30Updated: 2014-09-08
A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro
CompletedNCT01000922
Start: 2006-06-30End: 2008-01-31Updated: 2015-07-29
Memory Aid by Intranasal Insulin in Diabetes (MemAID)
CompletedNCT02415556
Start: 2015-10-06End: 2020-05-31Updated: 2022-05-19
Phase 3
A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition
TerminatedNCT00287066
Start: 2006-02-28End: 2007-03-31Target: 22Updated: 2008-02-21
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus
CompletedNCT00542724
Start: 2006-09-30Updated: 2015-08-03
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus
CompletedNCT00542633
Start: 2006-12-31Updated: 2015-08-18
Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin
NCT00668850
Start: 2008-04-30End: 2011-09-30Target: 500Updated: 2011-06-08
Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.
CompletedNCT00849576
Start: 2008-04-30End: 2008-08-31Updated: 2015-08-03
Phase 4
Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study
NCT01417897
Start: 2011-09-30End: 2012-05-31Target: 12Updated: 2012-03-05
Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
CompletedNCT02443402
Start: 2016-01-31End: 2016-12-31Updated: 2018-02-06
Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
CompletedNCT02556918
Start: 2016-01-31End: 2018-11-06Updated: 2019-12-23